🇺🇸 FDA
Patent

US 10864252

Anti-SSX-2 T cell receptors and related materials and methods of use

granted A61KA61K31/706A61K38/08

Quick answer

US patent 10864252 (Anti-SSX-2 T cell receptors and related materials and methods of use) held by THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services expires Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services
Grant date
Tue Dec 15 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 10 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K31/706, A61K38/08, A61K38/10, A61K38/177